Nolvadex Tablets (Tamoxifen Citrate 10mg & 20mg) | Selective Estrogen Receptor Modulator for Breast Cancer Therapy & Hormone Regulation

Product Description

Product Overview and Introduction

Target estrogen-sensitive pathways, manage breast cancer protocols, and support endocrine health with Nolvadex Tablets (Tamoxifen Citrate). As a foundational prescription selective estrogen receptor modulator (SERM) trusted worldwide by oncologists and endocrinologists, Nolvadex is a cornerstone medication in the treatment of hormone receptor-positive breast cancer across adjuvant, metastatic, and risk-reduction settings. Engineered to interact specifically with estrogen receptors throughout the body, it provides nuanced, tissue-specific hormonal regulation.

At the core of Nolvadex is tamoxifen citrate, a synthetic nonsteroidal agent that acts as a competitive partial agonist and antagonist of estrogen receptors. In breast tissue, tamoxifen functions as an antagonist by binding to estrogen receptors, thereby blocking circulating estrogen from stimulating the growth and division of hormone-receptor-positive cancer cells. Conversely, it exhibits agonist-like effects in other tissues such as bone and the liver, helping to maintain bone mineral density while modulating lipid profiles.

Key Engineering and Clinical Highlights

Manufactured under strict pharmaceutical controls to ensure high systemic bioavailability, precise micro-dosing, and consistent potency, Nolvadex delivers rigorous clinical performance:

• Tissue-Specific SERM Activity: Selectively blocks estrogenic stimulation in breast tissue while preserving beneficial estrogenic activity in bone and lipid pathways.

• Oncological Efficacy: Proven in landmark clinical trials to significantly reduce recurrence rates and improve overall survival in hormone receptor-positive breast cancer patients.

• Hormone Regulation Utility: Frequently utilized in specialized endocrine and post-cycle protocols to modulate estrogen feedback loops and stimulate endogenous hormone production under medical supervision.

• Standardized Dosage Strengths: Available in precision-formulated 10mg and 20mg tablet formulations to accommodate exact oncology and therapeutic dosing regimens.

The Definitive Global Standard in SERM Endocrine Care

When clinical oncology and advanced medical protocols require a proven, highly reliable selective estrogen receptor modulator to suppress estrogen-driven cell proliferation and support systemic endocrine balance, Nolvadex stands out as an indispensable therapeutic standard.

Key Features and Benefits

• Targeted Antiestrogenic Defense: Effectively starves hormone-sensitive breast lesions of the estrogen signals required for tumor growth.

• Proven Clinical History: Decades of extensive global application backed by exhaustive safety data, pharmacokinetic tracking, and established medical guidelines.

Specifications

• Product Type: Prescription Selective Estrogen Receptor Modulator (SERM) / Antineoplastic Agent

• Active Ingredient: Tamoxifen Citrate (Available in 10mg and 20mg oral tablet strengths)

• Indication: Treatment of Hormone Receptor-Positive Breast Cancer (Adjuvant and Metastatic), Reduction of Risk in High-Risk Patients, and Specialized Endocrine Management

• Packaging: Pharmaceutical Blister Packs or Dispensing Bottles (Quantity varies by prescription protocol)

• Administration Route: Oral Tablet

• Condition: Brand New Pharmaceutical Grade (Requires Strict Prescription and Medical Supervision)

Additional Information